89 related articles for article (PubMed ID: 22888653)
1. [The role of functional status and recursive partition analysis (RPA) classes for the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):369-73. PubMed ID: 22888653
[TBL] [Abstract][Full Text] [Related]
2. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654
[TBL] [Abstract][Full Text] [Related]
3. [The role of RPA classification in the treatment of high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV; Zotov VK
Vopr Onkol; 2012; 58(4):521-6. PubMed ID: 23607208
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation the effectiveness of radiation therapy high-grade gliomas based on the model of TDF (time-dose fractionation)].
Izmaĭlov TR; Pan'shin GA; Misliukov SM; Datsenko PV
Vopr Onkol; 2013; 59(5):629-35. PubMed ID: 24260893
[TBL] [Abstract][Full Text] [Related]
5. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of predictors influencing the results of the combined treatment for anaplastic astrocytomas (grade III) of the brain].
Solodky VA; Panshin GA; Bychkov YM; Anashkina MV; Milyukov SM; Izmailov TR
Vopr Onkol; 2015; 61(1):25-30. PubMed ID: 26016141
[TBL] [Abstract][Full Text] [Related]
7. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
8. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.
Brada M; Sharpe G; Rajan B; Britton J; Wilkins PR; Guerrero D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):287-92. PubMed ID: 10030251
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.
Farzin M; Molls M; Astner S; Rondak IC; Oechsner M
Strahlenther Onkol; 2015 Dec; 191(12):945-52. PubMed ID: 26340939
[TBL] [Abstract][Full Text] [Related]
11. Fractionated Radiotherapy of Intracranial Gliomas.
Ghia AJ
Prog Neurol Surg; 2018; 31():38-47. PubMed ID: 29393175
[TBL] [Abstract][Full Text] [Related]
12. Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas.
Gupta T; Dutta D; Trivedi S; Upasani M; Jalali R; Sarin R
J Cancer Res Ther; 2010; 6(3):272-7. PubMed ID: 21119252
[TBL] [Abstract][Full Text] [Related]
13. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
14. A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy.
Phuong PC; Nam LV; Schild SE; Rades D; Khoa MT
In Vivo; 2017; 31(4):689-693. PubMed ID: 28652440
[TBL] [Abstract][Full Text] [Related]
15. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
16. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
[TBL] [Abstract][Full Text] [Related]
17. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
18. The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas.
Sayin MY; Kaya B; Bakkal BH; Altundag K; Altundag MB
Med Oncol; 2007; 24(4):379-83. PubMed ID: 17917085
[TBL] [Abstract][Full Text] [Related]
19. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors and long-term results of radiotherapy in grade-3 and -4 brain neoplasms].
Ismaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2010; 56(5):565-70. PubMed ID: 21137236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
